Hepatic stellate cell enriched Asporin drives liver fibrosis by stabilizing ERH to promote IL-17/MAPK11 signaling
Summary
No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.
Summarise with VIRAT Free to try with your Science Catalogs account.Abstract
and high-fat diet induced fibrosis models, prasugrel alleviated fibrosis, inflammation, lipid accumulation, and portal hypertension by suppressing Asporin and ERH expression. Collectively, these findings define the Asporin/ERH/IL-17/MAPK11 axis as a key mediator of HSC activation and fibrogenesis and highlight prasugrel as a promising anti-fibrotic therapy.
Fields of Study & Subjects
Liver physiology and pathology
Liver Disease Diagnosis and Treatment
Liver Diseases and Immunity
Publication details
- Journal / source
- Acta Pharmaceutica Sinica B
- Volume
- 16
- Issue
- 7
- Pages
- 4350–4366
- Publication date
- 31 March 2026
- Language
- EN